Hirai H, Taketa K
Tumour Laboratory, Kokubunji, Tokyo, Japan.
J Chromatogr. 1992 Jun 26;604(1):91-4. doi: 10.1016/0021-9673(92)85532-x.
alpha-Fetoprotein (AFP) is widely used as a marker of hepatocellular carcinoma (HCC) for assisting diagnosis and also for screening purposes, even though its sensitivity has been decreased slightly as a result of the earlier detection of HCC by ultrasonography. Using lectin-dependent fractionation of AFP, the diagnostic sensitivity as well as the specificity of AFP can be increased compared with measurement of total AFP. Furthermore, lectin-reactive forms of AFP, AFP-L3 and AFP-P4, have been shown to serve as preclinical markers of HCC. Accordingly, AFP is still the most reliable marker of HCC in screening and monitoring high-risk patients.
甲胎蛋白(AFP)被广泛用作肝细胞癌(HCC)的标志物,以辅助诊断和用于筛查目的,尽管由于通过超声检查更早地发现HCC,其敏感性略有下降。通过凝集素依赖的AFP分级分离,与总AFP测量相比,AFP的诊断敏感性以及特异性均可提高。此外,AFP的凝集素反应性形式,即AFP-L3和AFP-P4,已被证明可作为HCC的临床前标志物。因此,在筛查和监测高危患者时,AFP仍然是HCC最可靠的标志物。